These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35699539)

  • 21. Case Report: Serial Cases: Prolongation of High Immunoglobulin G Level in Repetitive COVID-19 Convalescence Plasma Donor in Saiful Anwar Hospital Malang, Indonesia.
    Nurarifah N; Brahmantyo HP; Wardhani SO; Hermanto DH; Arsana PM
    Front Immunol; 2021; 12():633323. PubMed ID: 34790190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma.
    Vandeberg P; Cruz M; Diez JM; Merritt WK; Santos B; Trukawinski S; Wellhouse A; Jose M; Willis T
    Transfusion; 2021 Jun; 61(6):1705-1709. PubMed ID: 33715160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
    Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
    Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
    Farrugia A
    Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
    [No Abstract]   [Full Text] [Related]  

  • 25. Persistence of SARS-CoV-2 nasopharyngeal swab PCR positivity in COVID-19 convalescent plasma donors.
    Ikegami S; Benirschke R; Flanagan T; Tanna N; Klein T; Elue R; Debosz P; Mallek J; Wright G; Guariglia P; Kang J; Gniadek TJ
    Transfusion; 2020 Dec; 60(12):2962-2968. PubMed ID: 32840002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
    Li L; Tong X; Chen H; He R; Lv Q; Yang R; Zhao L; Wang J; Xu H; Liu C; Chen G; Chen S; Li C; Qiao J; Yang J; Wu Y; Liu Z
    Transfusion; 2020 Aug; 60(8):1765-1772. PubMed ID: 32627216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors.
    Jahrsdörfer B; Groß R; Seidel A; Wettstein L; Ludwig C; Schwarz T; Körper S; Rojewski M; Lotfi R; Weinstock C; Seifried E; Corman VM; Drosten C; Münch J; Schrezenmeier H
    J Immunol; 2021 Jun; 206(11):2614-2622. PubMed ID: 33980583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors.
    Martin MC; Jimenez A; Ortega N; Parrado A; Page I; Gonzalez MI; Blanco-Peris L
    PLoS One; 2022; 17(2):e0264124. PubMed ID: 35202394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 convalescent plasma: current status, lessons from the past and future perspectives.
    Hervig TA; Flesland Ø; Nissen-Meyer LSH
    Transfus Apher Sci; 2022 Aug; 61(4):103487. PubMed ID: 35778352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Google Trends demonstrate public interest in COVID-19 convalescent plasma therapy.
    Adkins BD; Booth GS
    J Clin Apher; 2021 Jun; 36(3):492-493. PubMed ID: 33340373
    [No Abstract]   [Full Text] [Related]  

  • 31. Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients.
    Strasser EF; Steininger PA; Korn K; Achenbach S; Tenbusch M; Cunningham S; Zimmermann R; Überla K; Hackstein H
    Transfusion; 2021 Feb; 61(2):368-374. PubMed ID: 33125162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motivators of and barriers to becoming a COVID-19 convalescent plasma donor: A survey study.
    Masser BM; Ferguson E; Thorpe R; Lawrence C; Davison TE; Hoad V; Gosbell IB
    Transfus Med; 2021 Jun; 31(3):176-185. PubMed ID: 33368777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.
    Zhang L; Pang R; Xue X; Bao J; Ye S; Dai Y; Zheng Y; Fu Q; Hu Z; Yi Y
    Aging (Albany NY); 2020 Apr; 12(8):6536-6542. PubMed ID: 32320384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [COVID-19: Still a place for the convalescent plasma? Focus on the immunocompromised patients].
    Richier Q; Hueso T; Tiberghien P; Lacombe K
    Rev Med Interne; 2023 Sep; 44(9):467-471. PubMed ID: 37689526
    [No Abstract]   [Full Text] [Related]  

  • 35. Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan.
    Suzuki T; Asai Y; Ide S; Fukuda S; Tanaka A; Shimanishi Y; Takahashi K; Terada M; Sato L; Sato M; Inada M; Yamada G; Miyazato Y; Akiyama Y; Nomoto H; Nakamoto T; Nakamura K; Togano T; Morioka S; Kinoshita-Iwamoto N; Saito S; Kutsuna S; Ohmagari N
    J Infect Chemother; 2022 Feb; 28(2):206-210. PubMed ID: 34756573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ABO blood type analysis of the donors of convalescent plasma after COVID-19 infection in Chelyabinsk region, Russia.
    Krokhin AA; Rusakov MN; Belyaeva SV; Galkin A; Suslova TA
    Vox Sang; 2022 Mar; 117(3):457-458. PubMed ID: 34268789
    [No Abstract]   [Full Text] [Related]  

  • 37. Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection.
    Hosseini P; Rahimi H; Najafabadi MM; Ghorbani A; Najafabadi SK; Faridzadeh A; Arabpour J; Khormali E; Deravi N
    Acta Med Indones; 2021 Jan; 53(1):86-95. PubMed ID: 33818411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upper age limits for convalescent plasma donation and treatment of COVID-19 patients: A further marker of ageism.
    Fedecostante M; O'Neill D; Pierri F; Carrieri B; Lattanzio F; Cherubini A
    Transfusion; 2021 Sep; 61(9):2799-2800. PubMed ID: 34227110
    [No Abstract]   [Full Text] [Related]  

  • 39. SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors.
    Dada A; Elhassan K; Bawayan RM; Albishi G; Hefni L; Bassi S; Sobahy T; Cupler E; AlBaz N; Wali G; Alraddadi B; Alshukairi AN
    Intervirology; 2022; 65(4):230-235. PubMed ID: 35378533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rethinking the role of COVID-19 convalescent plasma in the critically ill.
    Casadevall A; Pirofski LA
    Transfus Apher Sci; 2023 Feb; 62(1):103521. PubMed ID: 35941021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.